跳至主要内容
临床试验/CTRI/2017/02/007918
CTRI/2017/02/007918尚未招募3 期

A randomized double blind controlled trial of erythropoietin for neonatal hypoxic ischemic encephalopathy

Department of Biotechnology0 个研究点目标入组 192 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
192

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.GA >35 wks and Birth weight > 1800 g
  • 2.PHYSIOLOGICAL CRITERIA- Any 1 of the following
  • a. ABG (Umbilical Cord/1st postnatal hr) pH < 7.0 or Base deficit (ABE) > - 12
  • b. Apgar score < 5 at 5â??
  • c. Ventilation required for at least 10â??as part of resuscitation
  • d. History of not having cried at birth
  • 3.NEUROLOGICAL CRITERIA- Seizures OR Evidence of moderate or severe encephalopathy (3 of 6 criteria in modified Sarnat)

排除标准

  • 1. Lack of consent 2. Major congenital malformations 3. Imminent death anticipated at the time of assessment for eligibility 4. PCV > 65% 5. Any thrombosis 6. Blood pressure > 97th Centile

研究者

发起方
Department of Biotechnology

相似试验

Erythropoietin in the treatment of birth asphyxia... | 临床试验